vs
CG Oncology, Inc.（CGON）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
CG Oncology, Inc.的季度营收约是Rigetti Computing, Inc.的1.2倍（$2.3M vs $1.9M），Rigetti Computing, Inc.净利率更高（-974.7% vs -1779.0%，领先804.3%），CG Oncology, Inc.同比增速更快（409.2% vs -17.9%），Rigetti Computing, Inc.自由现金流更多（$-19.5M vs $-36.2M）
CG Oncology是一家临床阶段生物技术企业，专注于开发针对泌尿生殖系统癌症的创新靶向免疫疗法，核心适应症包括非肌层浸润性膀胱癌，主要面向美国市场推进管线候选药物研发，以满足相关未被满足的临床需求。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
CGON vs RGTI — 直观对比
营收规模更大
CGON
是对方的1.2倍
$1.9M
营收增速更快
CGON
高出427.1%
-17.9%
净利率更高
RGTI
高出804.3%
-1779.0%
自由现金流更多
RGTI
多$16.7M
$-36.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.3M | $1.9M |
| 净利润 | $-41.3M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -2097.3% | -1209.7% |
| 净利率 | -1779.0% | -974.7% |
| 营收同比 | 409.2% | -17.9% |
| 净利润同比 | -29.9% | 88.1% |
| 每股收益（稀释后） | $-0.52 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CGONRGTI
| Q4 25 | $2.3M | $1.9M | ||
| Q3 25 | $1.7M | $1.9M | ||
| Q2 25 | $0 | $1.8M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | $456.0K | $2.3M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | $529.0K | $3.1M |
净利润CGONRGTI
| Q4 25 | $-41.3M | $-18.2M | ||
| Q3 25 | $-43.8M | $-201.0M | ||
| Q2 25 | $-41.4M | $-39.7M | ||
| Q1 25 | — | $42.6M | ||
| Q4 24 | $-31.8M | $-153.0M | ||
| Q3 24 | — | $-14.8M | ||
| Q2 24 | — | $-12.4M | ||
| Q1 24 | $-16.9M | $-20.8M |
毛利率CGONRGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率CGONRGTI
| Q4 25 | -2097.3% | -1209.7% | ||
| Q3 25 | -3069.0% | -1055.4% | ||
| Q2 25 | — | -1103.9% | ||
| Q1 25 | — | -1469.6% | ||
| Q4 24 | -8344.1% | -813.3% | ||
| Q3 24 | — | -729.4% | ||
| Q2 24 | — | -521.2% | ||
| Q1 24 | -4247.4% | -543.4% |
净利率CGONRGTI
| Q4 25 | -1779.0% | -974.7% | ||
| Q3 25 | -2629.5% | -10321.9% | ||
| Q2 25 | — | -2201.8% | ||
| Q1 25 | — | 2895.3% | ||
| Q4 24 | -6973.7% | -6726.5% | ||
| Q3 24 | — | -623.8% | ||
| Q2 24 | — | -402.5% | ||
| Q1 24 | -3200.8% | -680.6% |
每股收益（稀释后）CGONRGTI
| Q4 25 | $-0.52 | $-0.08 | ||
| Q3 25 | $-0.57 | $-0.62 | ||
| Q2 25 | $-0.54 | $-0.13 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | $-0.47 | $-0.80 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | $-0.36 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $742.2M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $752.6M | $546.2M |
| 总资产 | $791.6M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CGONRGTI
| Q4 25 | $742.2M | $44.9M | ||
| Q3 25 | $680.3M | $26.1M | ||
| Q2 25 | $661.1M | $57.2M | ||
| Q1 25 | — | $37.2M | ||
| Q4 24 | $742.0M | $67.7M | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $20.7M | ||
| Q1 24 | $566.5M | $35.1M |
股东权益CGONRGTI
| Q4 25 | $752.6M | $546.2M | ||
| Q3 25 | $687.6M | $371.8M | ||
| Q2 25 | $670.4M | $553.3M | ||
| Q1 25 | — | $207.1M | ||
| Q4 24 | $733.4M | $126.6M | ||
| Q3 24 | — | $122.8M | ||
| Q2 24 | — | $122.2M | ||
| Q1 24 | $568.9M | $115.6M |
总资产CGONRGTI
| Q4 25 | $791.6M | $666.6M | ||
| Q3 25 | $729.9M | $630.3M | ||
| Q2 25 | $701.4M | $636.7M | ||
| Q1 25 | — | $269.1M | ||
| Q4 24 | $754.8M | $284.8M | ||
| Q3 24 | — | $157.3M | ||
| Q2 24 | — | $162.4M | ||
| Q1 24 | $579.1M | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-36.2M | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | $-36.2M | $-19.5M |
| 自由现金流率自由现金流/营收 | -1560.0% | -1042.5% |
| 资本支出强度资本支出/营收 | 0.3% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-124.1M | $-77.2M |
8季度趋势，按日历期对齐
经营现金流CGONRGTI
| Q4 25 | $-36.2M | $-14.9M | ||
| Q3 25 | $-38.9M | $-13.8M | ||
| Q2 25 | $-28.0M | $-16.2M | ||
| Q1 25 | — | $-13.7M | ||
| Q4 24 | $-20.7M | $-8.5M | ||
| Q3 24 | — | $-15.4M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | $-26.0M | $-13.1M |
自由现金流CGONRGTI
| Q4 25 | $-36.2M | $-19.5M | ||
| Q3 25 | $-39.0M | $-19.7M | ||
| Q2 25 | $-28.0M | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | $-20.9M | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | $-26.0M | $-18.6M |
自由现金流率CGONRGTI
| Q4 25 | -1560.0% | -1042.5% | ||
| Q3 25 | -2340.4% | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | -4577.0% | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | -4919.5% | -610.5% |
资本支出强度CGONRGTI
| Q4 25 | 0.3% | 244.8% | ||
| Q3 25 | 5.8% | 302.5% | ||
| Q2 25 | — | 314.7% | ||
| Q1 25 | — | 173.0% | ||
| Q4 24 | 45.8% | 56.4% | ||
| Q3 24 | — | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | 2.3% | 180.0% |
现金转化率CGONRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CGON
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
